Turenne Capital logo

Turenne Capital

Europe, Ile-de-France, France, Paris

Description

Turenne Capital is a leading French private equity and venture capital firm, headquartered in Paris, with a significant footprint in the domestic investment landscape. As a key player in capital investment, the firm manages an impressive portfolio exceeding €1.5 billion in assets under management. Turenne Capital is dedicated to fostering the growth and development of French small and medium-sized enterprises (SMEs) and mid-cap companies, providing crucial financial and strategic support across various stages of their lifecycle.

The firm employs a multi-faceted investment strategy, encompassing Capital Innovation, Capital Développement, Capital Transmission, and Capital Santé. Their Capital Innovation arm specifically targets early-stage and innovative companies, providing venture capital funding to promising startups. For these ventures, Turenne Capital typically deploys initial cheques ranging from €0.5 million to €5 million, aiming to fuel their initial growth and market penetration. Beyond early-stage investments, their Capital Développement and Capital Transmission strategies focus on growth equity and buyout opportunities, respectively, for more mature businesses.

With over two decades of experience, Turenne Capital boasts a robust track record, having supported more than 250 companies since its inception. This extensive portfolio reflects their commitment to driving economic expansion and innovation across diverse sectors within France. The firm prides itself on establishing long-term partnerships with its portfolio companies, offering not just capital but also strategic guidance and operational expertise to help them achieve their full potential and contribute to the broader French economy.

Investor Profile

Turenne Capital has backed more than 53 startups, with 3 new investments in the last 12 months alone. The firm has led 14 rounds, about 26% of its total and boasts 6 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series A, Private Equity rounds (top funding stages).
  • Majority of deals are located in France, Germany, United States.
  • Strong thematic focus on Software, Biotechnology, Health Care.
  • Led 1 rounds in the past year.
  • Typical check size: $540K – $5.4M.

Stage Focus

  • Series Unknown (38%)
  • Series A (25%)
  • Private Equity (15%)
  • Series B (13%)
  • Seed (6%)
  • Series C (4%)

Country Focus

  • France (91%)
  • Germany (6%)
  • United States (2%)
  • Poland (2%)

Industry Focus

  • Software
  • Biotechnology
  • Health Care
  • Medical
  • Internet
  • Information Technology
  • E-commerce
  • Manufacturing
  • Medical Device
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Turenne Capital frequently co-invest with?

Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 4
XAnge
Europe, Ile-de-France, France, Paris
Co-Investments: 3
ACG Management
Europe, Provence-Alpes-Cote d'Azur, France, Marseille
Co-Investments: 2
Région Sud Investissement
Europe, Provence-Alpes-Cote d'Azur, France, Marseille
Co-Investments: 2
Paca Investissement
Europe, Ile-de-France, France, Paris
Co-Investments: 5
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
IRDI SORIDEC Gestion
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 2
CTI Life Sciences Fund
North America, Quebec, Canada, Montréal
Co-Investments: 2
BNP Paribas Développement
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 7

Which angels does Turenne Capital often collaborate with?

CR
Europe, Geneve, Switzerland, Geneva
Shared Deals: 1
TE
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1

What are some of recent deals done by Turenne Capital?

Germitec SAS

Ivry-sur-seine, Ile-de-France, France

Germitec is a healthcare company that designs, Commercialize UV-C disinfection systems for hospital hygiene system.

Health CareMedical
Series BFeb 12, 2025
Amount Raised: $30,043,719
Coave Therapeutics

Paris, Ile-de-France, France

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

BiotechnologyGeneticsLife ScienceNeuroscience
Series AJan 9, 2025
Amount Raised: $32,948,556
Sydev

Échirolles, Rhone-Alpes, France

Sydev is a publisher of management software and tariff databases for technical building trades in the construction industry.

ComputerConstructionSoftware
Series UnknownSep 27, 2024
Amount Raised: $11,059,784
Antabio

Labège, Midi-Pyrenees, France

Antabio is a private biopharmaceutical company developing antibacterial resistance-breakers in areas of highest medical need.

BiotechnologyLife ScienceMedical Device
Series BDec 12, 2023
Amount Raised: $26,996,237
AlgoTherapeutix

Suresnes, Ile-de-France, France

AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.

BiotechnologyInformation TechnologyPharmaceutical
Series BMar 14, 2023
Amount Raised: $21,453,404
Amolyt Pharma

Écully, Rhone-Alpes, France

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

BiotechnologyHealth CareMedicalPharmaceuticalWellness
Series CJan 6, 2023
Amount Raised: $138,629,699
Tradim

Paris, Ile-de-France, France

Tradim offers integrated software and hardware for waste collection management and treatment.

HardwareSoftwareSoftware EngineeringWaste Management
Series UnknownOct 13, 2022
Amount Raised: $19,534,760
Domain Therapeutics

Illkirch, Alsace, France

Domain Therapeutics develops small molecules targeting G-coupled protein receptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AMay 10, 2022
Amount Raised: $41,063,697
PathoQuest

Paris, Ile-de-France, France

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

BiotechnologyHealth CareTherapeutics
Series BNov 9, 2021
Amount Raised: $17,391,748
AI Verse

Sophia Antipolis, Provence-Alpes-Cote d'Azur, France

AI Verse offers a self-service image factory that produces high-quality labeled synthetic datasets for training Computer Vision applications

Artificial Intelligence (AI)Machine Learning
SeedSep 1, 2021
Amount Raised: $2,960,374